Genomic Medicine Institute
The Genomic Medicine Institute partners with patients, healthcare providers and researchers worldwide to enhance the quality of life through research, education and clinical care innovation in genomic medicine. The institute conducts innovative research in genetics, genomics and family history to enhance the quality of life and improve healthcare value for patients.
Geisinger Genomic Council encourages the use of reference laboratories that have pledged to contribute past, present and future genomic data including genotype and phenotype to national databases to increase medical knowledge and improve patient care. Data from clinical testing should be made publicly available while respecting patient confidentiality. - Adopted October 15, 2014, reaffirmed July 12, 2017.
A list of reference laboratories in compliance with data sharing can be found here.
Adam Buchanan, MS, MPH, CGC
- Adam Buchanan, MS, MPH, CGC
- Samuel Gidding, MD
- Jing Hao, PhD, MD, MS, MPH
- Laney Jones, PharmD, MPH
- Ming Ta Michael Lee, PhD
- Jennifer Malinowski, PhD
- Monica McClain, PhD
- Alanna Kulchak Rahm, PhD, MS, CGC
- Amy Curry Sturm, MS, CGC
- Karen Wain, MS, CGC
- Marc S. Williams, MD
MyCode provides reports to patients that may help prevent or detect certain conditions at an early, treatable, stage.
DETECT Research Study
Can a blood test detect cancer? We are researching blood specimens to look for circulating tumor DNA and protein markers.
Clinical Genome Resource
Dedicated to determining which genetic variants are most relevant to patient care.
Join our team
Geisinger research pursues an ambitious agenda with the long-term goal of directly impacting the health of our patients, our community and health care as a whole. A unique aspect of Geisinger research is that, unlike traditional academic approaches, scientists are integrally connected to the clinical enterprise. This facilitates interdisciplinary team-based collaborations to address clinically relevant questions.